Most targets were associated with cancer, the PI3K-AKT signaling pathway and hepatitis B. The targets with the largest number of participating pathways were AKT1, RELA, and MAPK1, which participate in 21, 19, and 19 pathways, respectively. The gene discussed is RELA; the disease is cancer.